The Annals Visit the PharmaCE website!
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     

The Annals of Pharmacotherapy: Vol. 28, No. 12, pp. 1347-1349.
© 1994 Harvey Whitney Books Company.
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haverkos, G.
Right arrow Articles by Imhoff, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haverkos, G.
Right arrow Articles by Imhoff, T.

Research Articles

Fatal seizures after flumazenil administration in a patient with mixed overdose

GP Haverkos, RP DiSalvo, and TE Imhoff

OBJECTIVE: To report a fatal case of refractory status epilepticus precipitated by flumazenil use in a mixed benzodiazepine-tricyclic antidepressant overdose. CASE SUMMARY: A 39-year-old woman was brought to the emergency room (ER) in a stupor from a suspected suicidal overdose of an unknown mixture of drugs. Past medical history included seizures and psychiatric disorders managed with benzodiazepine and tricyclic antidepressants. Initial ER electrocardiogram showed a QRS interval of 136 milliseconds. The patient developed refractory seizures after being given flumazenil. Lorazepam, phenytoin, and phenobarbital were administered; however, seizures persisted for 4 hours, resulting in rhabdomyolysis, acute renal failure, severe brain damage, and death. DISCUSSION: Flumazenil should be used with caution in patients with chronic benzodiazepine use, prior seizure history, or when a mixed overdose is suspected. Flumazenil may unmask tricyclic antidepressant-induced seizures by antagonizing the antiepileptic effect of concomitantly ingested benzodiazepine. In this patient seizures occurred within two minutes of flumazenil administration. As benzodiazepine-induced central nervous system depression is rarely life-threatening, the use of flumazenil must be balanced against potential risk. CONCLUSIONS: Seizure risk factors should be assessed in all patients in whom flumazenil use is considered. If risk factors are present, the benefit of flumazenil use is outweighed by the potential risk. If flumazenil is used, resulting seizures may require larger doses of benzodiazepine.


This article has been cited by other articles:


Home page
 Postgrad. Med. J.Home page
S L Greene, P I Dargan, and A L Jones
Acute poisoning: understanding 90% of cases in a nutshell
Postgrad. Med. J., April 1, 2005; 81(954): 204 - 216.
[Abstract] [Full Text] [PDF]

Home page
 Emerg. Med. J.Home page
R Lynch
Tricyclic antidepressant overdose
Emerg. Med. J., November 1, 2002; 19(6): 596 - 596.
[Full Text] [PDF]

Home page
 Journal of Pharmacy PracticeHome page
H. Cohen, R. S. Hoffman, and M. A. Howland
Antidepressant Poisoning and Treatment: A Review and Case Illustration
Journal of Pharmacy Practice, August 1, 1997; 10(4): 249 - 270.
[Abstract] [PDF]

Home page
 BMJHome page
N Nichol, L Pieterse, and T Beattie
Naloxone infusion should have been started earlier
BMJ, December 7, 1996; 313(7070): 1479c - 1480.
[Full Text]


homecopy help contact us subscription past issues search current issue
Copyright © 1994 by Harvey Whitney Books Company.